YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Gilead to buy Kite Pharma for $11B

Posted online

Gilead Sciences agreed to buy Kite Pharma for $11 billion, people familiar with the matter told Dow Jones Newswires.

The all-cash deal would give Gilead access to Kite Pharma's new technology designed to harness the body's immune system to fight cancer.

Foster City, California-based Gilead's portfolio includes infectious-disease treatments.

Read more from Dow Jones Newswires.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences